0-10 importance and confidence rulers, 278
25(OH)D, 245, 246
A
AAP. See American Academy of Pediatrics
(AAP)
Abdominal ultrasound, 244
Academy of Nutrition and Dietetics, 296
Acarbose, 414
Accelerometer, 323, 329
ACEI. See Angiotensin-converting enzyme
inhibitor (ACEI)
Acoustic radiation force imaging, 244
Action reflections, 273, 274t
Activity logs, 323
Activity monitors, 302
Adenotonsillar hypertrophy, 350, 352
Adenotonsillectomy, 352–353
Adipocyte protein 2 (aP2), 398
Adiponectin (ADIPOQ), 397
Adjustable gastric band, 225–226
Adrenarche, 368
Adrenocortical insufficiency, 433
African Americans. See Race and ethnicity
Agouti-related peptide (AGRP), 380, 381f
Alanine aminotransferase (ALT), 237, 241t,
242, 243, 336, 337t, 338, 340
Albright hereditary osteodystrophy, 234f, 235,
388t
Albuminuria, 434
Alcohol, 418, 437–438
ALMS1 gene, 234
ALMS1 syndrome, 396
Alpha-1 antitrypsin deficiency, 244t, 337t
Alpha-glucosidase inhibitors, 414
a-MSH, 380
Alström syndrome, 234, 234f, 388t
ALT. See Alanine aminotransferase (ALT)
Ambulatory blood pressure testing, 345
American Academy of Pediatrics (AAP)
annual wellness examination, 327
eating disorders, 216–217
IHELLP Social History Questions, 217, 218t
patient-centered communication styles, 305
routine health screening, 322
screen time use, 213–214
snoring, 215
American’s Best Health Plans, 322
Amplified negative reflections, 274t
Amylin receptor agonists, 414
Angiotensin-converting enzyme inhibitor
(ACEI), 348
Angiotensin receptor blocker, 348
Animas OneTouch Ping, 450t
Animas Vibe, 450t
Antihyperglycemic therapies, 414
aP2. See Adipocyte protein 2 (aP2)
Apneas, 351
Apps
health and fitness, 221–222
weight-focused, 287, 301–303
Aromatase, 364, 364f
Aromatization of androgens, 364, 364f
Artificial pancreas, 446, 455–457
Ask-tell-ask, 280
Aspartate aminotransferase (AST), 237, 241t,
242
AST. See Aspartate aminotransferase (AST)
Atkins diet, 290
Attribution theory, 258
Atypical diabetes mellitus, 426t
Autoimmune hepatitis, 244t, 337t
AutoSyringe, 446
B
Bannayan-Riley-Ruvalcaba syndrome, 391t
Bardet-Biedl syndrome (BBS), 234f, 235, 386,
388–389t
Bariatric surgery, 225–226, 246, 340, 395,
414–415
Basal-bolus insulin injection, 447–448, 448f
Basal insulin therapy, 411
BBS. See Bardet-Biedl syndrome (BBS)
BBS genes, 235
BDMR. See Brachydactyly mental retardation
syndrome (BDMR)
BDNF. See Brain-derived neurotrophic factor
(BDNF)
BDNF mutations, 382t, 384
BEARS instrument, 215
Beckwith-Wiedemann syndrome, 391t
Behavioral Risk Factor Surveillance System, 323
Behavioral weight loss intervention programs
frequent self-weighing, 304–305
mindful eating, 297–298
more intensive intervention model, 288
Adolesc Med 028 (2017) 461–476
Note: Page numbers of articles are in boldface type. Page references followed by “f and “t denote
figures and tables, respectively.
Previous Page Next Page